 Polycystic Kidney, Autosomal Dominant
"Polycystic Kidney, Autosomal Dominant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.
| Descriptor ID |
D016891
|
| MeSH Number(s) |
C12.777.419.403.875.500 C13.351.968.419.403.875.500 C16.131.077.717.500 C16.320.798.500
|
| Concept/Terms |
Polycystic Kidney, Autosomal Dominant- Polycystic Kidney, Autosomal Dominant
- Kidney, Polycystic, Autosomal Dominant
- Polycystic Kidney Disease, Adult
- Adult Polycystic Kidney Disease
- Polycystic Kidney Disease, Autosomal Dominant
- Autosomal Dominant Polycystic Kidney
- ADPKD
Polycystic Kidney, Type 2 Autosomal Dominant Disease- Polycystic Kidney, Type 2 Autosomal Dominant Disease
- Polycystic Kidney Disease, Adult, Type II
- Polycystic Kidney Disease, Type 2
- Polycystic Kidney Disease, Adult Type 2
- Adult Polycystic Kidney Disease Type 2
- Polycystic Kidney Disease 2
|
Below are MeSH descriptors whose meaning is more general than "Polycystic Kidney, Autosomal Dominant".
- Diseases [C]
- Male Urogenital Diseases [C12]
- Urologic Diseases [C12.777]
- Kidney Diseases [C12.777.419]
- Kidney Diseases, Cystic [C12.777.419.403]
- Polycystic Kidney Diseases [C12.777.419.403.875]
- Polycystic Kidney, Autosomal Dominant [C12.777.419.403.875.500]
- Female Urogenital Diseases and Pregnancy Complications [C13]
- Female Urogenital Diseases [C13.351]
- Urologic Diseases [C13.351.968]
- Kidney Diseases [C13.351.968.419]
- Kidney Diseases, Cystic [C13.351.968.419.403]
- Polycystic Kidney Diseases [C13.351.968.419.403.875]
- Polycystic Kidney, Autosomal Dominant [C13.351.968.419.403.875.500]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Congenital Abnormalities [C16.131]
- Abnormalities, Multiple [C16.131.077]
- Polycystic Kidney Diseases [C16.131.077.717]
- Polycystic Kidney, Autosomal Dominant [C16.131.077.717.500]
- Genetic Diseases, Inborn [C16.320]
- Polycystic Kidney Diseases [C16.320.798]
- Polycystic Kidney, Autosomal Dominant [C16.320.798.500]
Below are MeSH descriptors whose meaning is more specific than "Polycystic Kidney, Autosomal Dominant".
This graph shows the total number of publications written about "Polycystic Kidney, Autosomal Dominant" by people in this website by year, and whether "Polycystic Kidney, Autosomal Dominant" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1998 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 2000 | 3 | 0 | 3 | | 2001 | 1 | 0 | 1 | | 2002 | 2 | 0 | 2 | | 2003 | 2 | 0 | 2 | | 2004 | 3 | 0 | 3 | | 2005 | 1 | 1 | 2 | | 2006 | 2 | 0 | 2 | | 2007 | 2 | 0 | 2 | | 2008 | 4 | 0 | 4 | | 2009 | 0 | 1 | 1 | | 2010 | 6 | 0 | 6 | | 2012 | 3 | 0 | 3 | | 2013 | 3 | 0 | 3 | | 2014 | 9 | 0 | 9 | | 2015 | 5 | 1 | 6 | | 2016 | 5 | 0 | 5 | | 2017 | 5 | 0 | 5 | | 2018 | 8 | 0 | 8 | | 2019 | 4 | 0 | 4 | | 2020 | 11 | 0 | 11 | | 2021 | 6 | 0 | 6 | | 2022 | 5 | 0 | 5 | | 2023 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Polycystic Kidney, Autosomal Dominant" by people in Profiles.
-
Steele CN, Nowak KL. Nonpharmacological Management of Autosomal Dominant Polycystic Kidney Disease. Adv Kidney Dis Health. 2023 May; 30(3):220-227.
-
Steele CN, Nowak KL. Targeting Glycosphingolipid Metabolism in ADPKD: Another Roadblock for Treatment. Am J Kidney Dis. 2023 05; 81(5):504-506.
-
Steele CN, Nowak KL. A Step Ahead toward Measuring Pain in Autosomal Dominant Polycystic Kidney Disease (ADPKD). Clin J Am Soc Nephrol. 2023 02 01; 18(2):160-162.
-
Nguyen DT, Kleczko EK, Dwivedi N, Monaghan MT, Gitomer BY, Chonchol MB, Clambey ET, Nemenoff RA, Klawitter J, Hopp K. The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression. JCI Insight. 2023 01 10; 8(1).
-
Klawitter J, Jackson MJ, Smith PH, Hopp K, Chonchol M, Gitomer BY, Cadnapaphornchai MA, Christians U, Klawitter J. Kynurenines in polycystic kidney disease. J Nephrol. 2023 01; 36(1):83-91.
-
Hoover E, Perrone RD, Rusconi C, Benson B, Dahl NK, Gitomer B, Manelli A, Mrug M, Park M, Seliger SL, Phadnis MA, Thewarapperuma N, Watnick TJ. Design and Basic Characteristics of a National Patient-Powered Registry in ADPKD. Kidney360. 2022 08 25; 3(8):1350-1358.
-
Klawitter J, Sempio C, Jackson MJ, Smith PH, Hopp K, Chonchol M, Gitomer BY, Christians U, Klawitter J. Endocannabinoid System in Polycystic Kidney Disease. Am J Nephrol. 2022; 53(4):264-272.
-
Bae KT, Tao C, Feldman R, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Mrug M, Bennett WM, Harris PC, Srivastava A, Landsittel DP, Abebe KZ. Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2022 03; 17(3):374-384.
-
Hopp K, Kleczko EK, Gitomer BY, Chonchol M, Klawitter J, Christians U, Klawitter J. Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease. Am J Physiol Renal Physiol. 2022 03 01; 322(3):F258-F267.
-
Nowak KL, Farmer-Bailey H, Wang W, You Z, Steele C, Cadnapaphornchai MA, Klawitter J, Patel N, George D, Jovanovich A, Soranno DE, Gitomer B, Chonchol M. Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD: A Randomized Controlled Trial. Clin J Am Soc Nephrol. 2022 02; 17(2):240-250.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|